Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants.

Hanlon P, Hanlon L, Marsh V, Byass P, Shenton F, Hassan-King M, Jobe O, Sillah H, Hayes R, M'Boge BH, et al.

Lancet. 1987 Jun 13;1(8546):1342-5.

PMID:
2884455
2.

Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.

Vesikari T, Isolauri E, D'Hondt E, Delem A, André FE, Zissis G.

Lancet. 1984 May 5;1(8384):977-81.

PMID:
6143964
3.

Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain.

Vodopija I, Baklaic Z, Vlatkovic R, Bogaerts H, Delem A, Andre FE.

Vaccine. 1986 Dec;4(4):233-6.

PMID:
3026106
4.

Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.

Moriniere BJ, van Loon FP, Rhodes PH, Klein-Zabban ML, Frank-Senat B, Herrington JE, Pallansch MA, Patriarca PA.

Lancet. 1993 Jun 19;341(8860):1545-50.

PMID:
8099637
5.

Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine.

Jalil F, Zaman S, Carlsson B, Glass RI, Kapikian AZ, Mellander L, Hanson LA.

Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):292-6.

PMID:
1653474
6.

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.

Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, Levine MM, Lewis K, Coia ML, Attah-Poku M, Ojwando J, Rivers SB, Victor JC, Nyambane G, Hodgson A, Schödel F, Ciarlet M, Neuzil KM.

Lancet. 2010 Aug 21;376(9741):606-14. doi: 10.1016/S0140-6736(10)60889-6. Epub 2010 Aug 6.

PMID:
20692030
7.

Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants.

Maldonado Y, Hestvik L, Wilson M, Townsend T, O'Hare J, Wee S, Yolken R.

J Pediatr. 1986 Dec;109(6):931-5.

PMID:
3537248
8.

Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants.

Flores J, Perez-Schael I, Gonzalez M, Garcia D, Perez M, Daoud N, Cunto W, Chanock RM, Kapikian AZ.

Lancet. 1987 Apr 18;1(8538):882-4.

PMID:
2882289
9.

Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.

Whittle HC, Rowland MG, Mann GF, Lamb WH, Lewis RA.

Lancet. 1984 Oct 13;2(8407):834-7.

PMID:
6148572
10.

Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.

Steele AD, Reynders J, Scholtz F, Bos P, de Beer MC, Tumbo J, Van der Merwe CF, Delem A, De Vos B.

J Infect Dis. 2010 Sep 1;202 Suppl:S93-100. doi: 10.1086/653550.

PMID:
20684724
11.

Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.

Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA.

JAMA. 1995 Apr 19;273(15):1191-6.

PMID:
7707626
13.
14.

Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine.

Ing DJ, Glass RI, Woods PA, Simonetti M, Pallansch MA, Wilcox WD, Davidson BL, Sievert AJ.

Am J Dis Child. 1991 Aug;145(8):892-7.

PMID:
1650128
15.

Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine.

Giammanco G, De Grandi V, Lupo L, Mistretta A, Pignato S, Teuween D, Bogaerts H, Andre FE.

Eur J Epidemiol. 1988 Mar;4(1):121-3.

PMID:
2833407
16.

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.

Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, Le HT, Coia ML, Lewis K, Rivers SB, Sack DA, Schödel F, Steele AD, Neuzil KM, Ciarlet M.

Lancet. 2010 Aug 21;376(9741):615-23. doi: 10.1016/S0140-6736(10)60755-6. Epub 2010 Aug 6.

PMID:
20692031
17.

Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.

Simasathien S, Migasena S, Samakoses R, Pitisuttitham P, Sangaroon P, Aree C, Bishop R, Bugg H, Davidson BL, Vesikari T.

Pediatr Infect Dis J. 1994 Jul;13(7):590-6.

PMID:
7970945
18.

Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.

Phua KB, Quak SH, Lee BW, Emmanuel SC, Goh P, Han HH, De Vos B, Bock HL.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S6-S16.

PMID:
16088807
19.
20.

Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.

Vesikari T, Joensuu J, Baer M, Käyhty H, Olander RM, Sormunen H, Miettinen A, Ward RL, Guillot T.

Acta Paediatr. 1999 May;88(5):513-20.

PMID:
10426173

Supplemental Content

Support Center